These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 22854667)
1. Model-based projections of the population-level impact of hepatitis A vaccination in Mexico. Van Effelterre T; De Antonio-Suarez R; Cassidy A; Romano-Mazzotti L; Marano C Hum Vaccin Immunother; 2012 Aug; 8(8):1099-108. PubMed ID: 22854667 [TBL] [Abstract][Full Text] [Related]
2. Modeling the hepatitis A epidemiological transition in Brazil and Mexico. Van Effelterre T; Guignard A; Marano C; Rojas R; Jacobsen KH Hum Vaccin Immunother; 2017 Aug; 13(8):1942-1951. PubMed ID: 28481680 [TBL] [Abstract][Full Text] [Related]
3. Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico. Carlos F; Gómez JA; Anaya P; Romano-Mazzotti L Hum Vaccin Immunother; 2016; 12(1):52-63. PubMed ID: 26503702 [TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination. Lazcano-Ponce E; Conde-Gonzalez C; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E Hum Vaccin Immunother; 2013 Feb; 9(2):375-81. PubMed ID: 23291940 [TBL] [Abstract][Full Text] [Related]
5. Modeling hepatitis A epidemiological profiles and estimating the pediatric vaccination threshold in the Russian Federation. Taratorkin FF; Karlsen AA; Kyuregyan KK; Lopatukhina MA; Khankishiyev F; Manuylov VA; Akimkin VG; Mikhailov MI Front Public Health; 2024; 12():1371996. PubMed ID: 38993707 [TBL] [Abstract][Full Text] [Related]
6. The role of ethnicity and travel on Hepatitis A vaccination coverage and disease incidence in Arizona at the United States-Mexico Border. Ernst KC; Erhart LM Hum Vaccin Immunother; 2014; 10(5):1396-403. PubMed ID: 24603091 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis A in Puglia (South Italy) after 10 years of universal vaccination: need for strict monitoring and catch-up vaccination. Chironna M; Prato R; Sallustio A; Martinelli D; Tafuri S; Quarto M; Germinario C BMC Infect Dis; 2012 Oct; 12():271. PubMed ID: 23098290 [TBL] [Abstract][Full Text] [Related]
8. The impact of assumptions regarding vaccine-induced immunity on the public health and cost-effectiveness of hepatitis A vaccination: Is one dose sufficient? Curran D; de Ridder M; Van Effelterre T Hum Vaccin Immunother; 2016 Nov; 12(11):2765-2771. PubMed ID: 27428611 [TBL] [Abstract][Full Text] [Related]
9. Modeling the hepatitis A epidemiological transition in Thailand. Van Effelterre T; Marano C; Jacobsen KH Vaccine; 2016 Jan; 34(4):555-562. PubMed ID: 26657185 [TBL] [Abstract][Full Text] [Related]
10. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine. Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907 [TBL] [Abstract][Full Text] [Related]
11. Progress Toward Eliminating Hepatitis A Disease in the United States. Murphy TV; Denniston MM; Hill HA; McDonald M; Klevens MR; Elam-Evans LD; Nelson NP; Iskander J; Ward JD MMWR Suppl; 2016 Feb; 65(1):29-41. PubMed ID: 26916458 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis A vaccine should receive priority in National Immunization Schedule in India. Verma R; Khanna P Hum Vaccin Immunother; 2012 Aug; 8(8):1132-4. PubMed ID: 22854671 [TBL] [Abstract][Full Text] [Related]
13. A dynamic model for assessing universal Hepatitis A vaccination in Canada. Bauch CT; Rao AS; Pham BZ; Krahn M; Gilca V; Duval B; Chen MH; Tricco AC Vaccine; 2007 Feb; 25(10):1719-26. PubMed ID: 17229493 [TBL] [Abstract][Full Text] [Related]
14. Challenges in Management of Hepatitis A Virus Epidemiological Transition in Mexico. Trujillo-Ochoa JL; Viera-Segura O; Fierro NA Ann Hepatol; 2019; 18(1):14-22. PubMed ID: 31113583 [TBL] [Abstract][Full Text] [Related]
15. Effect of hepatitis A vaccination programs for migrant children on the incidence of hepatitis A in The Netherlands. Suijkerbuijk AW; Lindeboom R; van Steenbergen JE; Sonder GJ; Doorduyn Y Eur J Public Health; 2009 Jun; 19(3):240-4. PubMed ID: 19174503 [TBL] [Abstract][Full Text] [Related]
16. Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review. Stuurman AL; Marano C; Bunge EM; De Moerlooze L; Shouval D Hum Vaccin Immunother; 2017 Mar; 13(3):724-736. PubMed ID: 27786671 [TBL] [Abstract][Full Text] [Related]
17. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination. Hussain Z; Das BC; Husain SA; Murthy NS; Kar P J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154 [TBL] [Abstract][Full Text] [Related]
18. Poor response to hepatitis A vaccination in hematopoietic stem cell transplant recipients. Adati EM; da Silva PM; Sumita LM; Rodrigues MO; Zanetti LP; Dos Santos ACF; de Souza MP; Colturato VR; Machado CM Transpl Infect Dis; 2020 Jun; 22(3):e13258. PubMed ID: 32034983 [TBL] [Abstract][Full Text] [Related]
19. Impact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil. Souto FJD; de Brito WI; Fontes CJF Vaccine; 2019 Feb; 37(6):771-775. PubMed ID: 30639462 [TBL] [Abstract][Full Text] [Related]
20. Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response. Mayorga O; Bühler S; Jaeger VK; Bally S; Hatz C; Frösner G; Protzer U; Van Damme P; Egger M; Herzog C J Infect Dis; 2016 Nov; 214(10):1498-1506. PubMed ID: 27601623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]